Festival of Biologics Basel
Join us in-person in Basel, Switzerland for the Festival of Biologics Basel where Just – Evotec Biologics will be presenting our science.
Who’s Attending
- Christelle Dagoneau, SVP Business Development
- Barbara Bachler-Konetzki, Group Leader – In Vitro Biology, Modality Lead for Biologics
- Nigel Shipston, Senior Director Business Development
-
Tanja Krainz, Director Business Development
Presentation | Tuesday, October 10, 2023 5:10 PM to 5:30 PM
Paradigm Shift in Biologics Manufacturing: Leveraging Continuous Manufacturing from First-in-Human Study to Market Supply
CMC & Developability track
Presented by Christelle Dagoneau, SVP Business Development
Presentation | Wednesday, October 11, 2023 4:50 PM to 5:10 PM
Evotec’s best-in-class Biologics continuum to support immunotherapy programs: the strength of integrating state-of-the art discovery technologies, & disease know-how
Antibodies for Immunotherapy track
Presented by Barbara Bachler-Konetzki, Group Leader – In Vitro Biology, Modality Lead for Biologics
Speakers
-
Barbara Bachler-KonetzkiGroup Leader, In Vitro PharmacologyBarbara received her PhD in Biomedicine and Biotechnology from the University of Veterinary Medicine in Vienna, Austria in collaboration with the Harvard Medical School / Dana-Farber Cancer Institute in Boston, USA where she focused on the profiling of protective anti-HIV antibody responses upon vaccination. After moving back to Europe, she continued to work on antibodies at MorphoSys, a biotech company based in Munich, Germany, well-known for the discovery and development of therapeutic antibodies using human antibody libraries by applying the in silico phage display technology. During this time, Barbara successfully discovered a novel acting therapeutic antibody, and progressed it all the way from concept to pre-clinical candidate nomination. In 2021, this molecule entered clinical phase 1 testing in immune oncology. Joining Evotec in 2018, she played a key role in the establishment of the streamlined hybridoma platform and the implementation of the ATX-Gx™ mice from Alloy as source of fully human antibodies. She is now leading a group of scientists and technicians supporting internal and external antibody programmes from target identification to lead candidate nomination.
-
Christelle DagoneauSVP Business DevelopmentChristelle has over 20 years of international business development and marketing experience in the life sciences and biologics CDMO industry. In her current role as SVP Business Development, Christelle leads the global Business Development team, with a focus on shaping innovative business strategies, building a strong industry presence and establishing Just – Evotec Biologics as a global leader in the AI-driven discovery to continuous manufacturing space. Prior to joining Just – Evotec Biologics, Christelle held several senior Business Development roles at Catalent where she supported the growth of the biologics division in Europe and led the European Cell Therapy Business Development team. Christelle also served as Head of Marketing and Sales at PX’Therapeutics, a French biologics CDMO and brings in an expert knowledge of the biotherapeutics and biosimilars markets, a passion for building strategic partnerships as well as strong Business Development culture and best practices.
Christelle received her Ph.D. in Organic Chemistry from the University of Grenoble, France and also holds a master in Technology & Business Management.